Gabapentin-Mepha Teva 100 mg

Gabapentin-Mepha Teva 100 mg is a medicine authorised by Swissmedic under authorisation number 69720. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 February 2025 and the authorisation is limited until 12 February 2030. ATC code N02BF01 places the medicine in the group Analgesics.

  • Dispensing category B
  • Authorisation number 69720
  • ATC N02BF01
  • Synthetic medicines
Authorisation data
Authorisation number69720
NameGabapentin-Mepha Teva 100 mg
Full nameGabapentin-Mepha Teva 100 mg, Hartkapseln
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN02BF01
First authorisation13 February 2025
Authorisation validity12 February 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Gabapentin-Mepha Teva 100 mg, HartkapselnB13 February 2025
2Gabapentin-Mepha Teva 300 mg, HartkapselnB13 February 2025
3Gabapentin-Mepha Teva 400 mg, HartkapselnB13 February 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
150Kapsel(n)N02BF0101.07.1.B
2100Kapsel(n)N02BF0101.07.1.B
7200Kapsel(n)N02BF0101.07.1.B
350Kapsel(n)N02BF0101.07.1.B
4100Kapsel(n)N02BF0101.07.1.B
8200Kapsel(n)N02BF0101.07.1.B
550Kapsel(n)N02BF0101.07.1.B
6100Kapsel(n)N02BF0101.07.1.B
9200Kapsel(n)N02BF0101.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Gabapentin-Mepha Teva 100 mg authorised in Switzerland?

Yes. Gabapentin-Mepha Teva 100 mg is authorised by Swissmedic under authorisation number 69720, data as of 01 September 2026. The authorisation is limited until 12 February 2030.

Which dispensing category does Gabapentin-Mepha Teva 100 mg have?

Gabapentin-Mepha Teva 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Gabapentin-Mepha Teva 100 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com